Log In
Print
BCIQ
Print
Print this Print this
 

Humira, adalimumab

Also known as: formerly D2E7

  Manage Alerts
Collapse Summary General Information
Company AbbVie Inc.
DescriptionHuman mAb against tumor necrosis factor (TNF) alpha
Molecular Target Tumor necrosis factor (TNF) alpha
Mechanism of ActionTumor necrosis factor (TNF) alpha inhibitor; Antibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today